KNTE
Kinnate Biopharma Inc.
Director and 10% owner Carl L Gordon bought $15.0M of Kinnate Biopharma Inc.
Bought$15,000,000
$20.00Price
750,000Shares
−250%Stake
What KNTE did for a copier
Prices for KNTE after this filing aren't in yet.
Carl L Gordon's record
15 other buys with 3 months of prices since 2016: on average −6.5% against the S&P 500, and 7 of 15 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Dec 2. Filed Fri, Dec 4. Not investment advice.